Outpatient inotropic infusions and the impact on quality of life in patients with advanced heart failure

Cardiovascular Reviews and Reports

Volumn 18, Issue 4, 1997, Pages 11-12+15

  Forgosh, Les ^a  

^a ARIZONA HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; MILRINONE;

HEART FAILURE; HUMAN; INOTROPISM; OUTPATIENT CARE; QUALITY OF LIFE; REVIEW;

EID: 8244262040     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Health Care Financing Administration. Med PAR Database. 1994.
2. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J. 1991; 121:951-957.
3. Dracup K, Walden JA, Stevenson LW, et al. Quality of life in patients with advanced heart failure. J Heart Lung Transplant. 1992; 11:273-279.
4. Grady KL, Jalowiec A, White-Williams C, et al. Predictors of quality of life in patients with advanced heart failure awaiting transplantation. J Heart Lung Transplant. 195;14:2-10.
5. Muirhead J, Meyerowitz B, Leedham B, et al. Quality of life and coping in patients awaiting heart transplantation. J Heart Lung Transplant. 1992;11:265-272.
6. Health Care Investment, Inc. Baltimore, MD. In: Field JL, Van Hoose M, managing consultants. Beyond four walls. Cost-effective management of chronic congestive heart failure. Washington DC: The Advisory Board Company; 1994:70.
7. Stevenson LW, Miller LW. Cardiac transplantation as therapy for heart failure. Curr Probl Cardiol. 1991;16(4):217-305.
8. United Network for Organ Sharing, 1992.
9. Braunwald E. Heart Failure. In: Isselbacher KJ, Braunwald E, Wilson JD, et al, (eds). Harrison's Principles of Internal Medicine, 13th ed. New York:McGraw-Hill; 1994(1):1007.
10. Unverferth DV, Blanford M, Kate RE, et al. Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med. 1980:69:262-266.
11. Shipley JB, Tolman D, Hastillo A, et al. Milrinone: Basic and clinical pharmacology and acute and chronic management. Am J Med Sci. 1996;36(6):1-6.
12. Honerjäger P, Nawrath H. Pharmacology of bipyridine phosphodiesterase III inhibitors. Eur J Anaesth. 1992 (suppl 5):7-14.
13. Heaney L, Marius-Nunez AL, Silber E, et al. Intermittent inotropic infusions: Critical care in an outpatient setting. CHF. 1995;1(5):13-18.
14. Rauh RA, Schwabaurer RN, Enger EL. A community hospital based congestive heart failure program: Impact on admission rate, length of stay, and readmission rate in an elderly population. Am J Geriatric Cardiol. 1996;2:51. Abstract.
15. Applefeld MM, Newman KA, Sutton FJ, et al. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: Clinical experience in 21 patients. Am Heart J. 1987;114:589-595.
16. Roth SNL, Moe G. Intermittent intravenous amrinone infusion: A potentially cost effective mode of treatment of patients with refractory heart failure. Can J Cardiol. 1993;9:231-237.
17. Wenger NK, Mattson ME, Furberg CD, et al. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq Publishing. 1984:2-3.
18. Lipkin DP, Scriven AJ, Crake T, et al. Six-minute walking test for assessing exercise capacity in chronic heart failure. Br Med J. 1986;292:653-655.
19. Nord E. EuroQol©: Health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy. 1991;18:25-36.
20. Rich MW, Beckham V, Wittenberg C, et al. A Multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl. J Med. 1995;333:1190-1195.
21. Friedman AW, Minella RA, Silver SJ, et al. Reduced hospital admissions with chronic inotropic therapy for resistant congestive heart failure. CHF. 1995;1(7):19-23.
22. Marius-Nunez AL, Heaney L, Silber E. The role of intermittent inotropic therapy in the heart failure clinic of Michael Reese Hospital and Medical Center. CHF. 1995;1(5):30-33.
23. Packer M, Carver JR, Rodeheffer RJ, et al. Effects of oral milrinone on mortality in severe chronic heart failure. N Eng J Med. 1991;325:1468-1475.
24. Dies F, Krell MJ, Whitlow P, et al. Intermittent, ambulatory dobutamine infusion in severe chronic cardiac failure. Br J Clin Prac. 1986;40(6 suppl 45):37-39.